Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

August 11, 2022
BioUtah News
Senate Passes Inflation Reduction Act – Sens. Lee, Romney Oppose

After an all-night session, the Senate on Sunday passed a sweeping, $740 billion reconciliation package titled the “Inflation Reduction.” The measure passed on a party line 51-50 vote, with Vice President Kamala Harris breaking the tie vote. The 755-page bill will now be taken up by the House today, where it is expected to pass […]

August 11, 2022
BioUtah News
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care Physicians

98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b. Published study complements KidneyIntelX clinical utility data published at American Diabetes Association Annual Conference demonstrating improvements in guideline recommended care, including therapeutic managements and specialist consultation […]

August 11, 2022
BioUtah News
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia 

Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics has announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336, an investigational small molecule inhibitor against the binding of menin and mixed-lineage leukemia (MLL) protein, for the treatment of acute myeloid leukemia (AML).  “We are pleased to have […]

August 11, 2022
BioUtah News
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update

PolarityTE provided a business update and reported financial results for the quarterly period ended June 30, 2022.

August 11, 2022
BioUtah News
Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platform

August 10, 2022
BioUtah News
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models

Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses

August 9, 2022
BioUtah News
Merit Medical Launches SafeGuard Focus Cool™ Compression Device

Modern design advances patient care by combining hemostasis with innovative cooling capability

August 8, 2022
BioUtah News
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelXTM with Primary Care Physicians

98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b.

August 8, 2022
BioUtah News
Soft Cell Labs announces new Urinary Tract Infection Test

Soft Cell Labs announces new Urinary Tract Infection Test

August 4, 2022
BioUtah News
ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories

ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of clinical chemistry analyzers

August 4, 2022
BioUtah News
bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

August 4, 2022
BioUtah News
3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business

New 3M will remain a leading global material science innovator serving diverse end markets, with science and technology, manufacturing, global capabilities, and iconic brands

August 3, 2022
BioUtah News Policy News
Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality

Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality

July 28, 2022
Policy News
Senate Democrats Push Drug Pricing, Tax, Climate Package

Sen. Joe Manchin (D-W. Va.) on Wednesday said he had signed off on a revised “Build Back Better” plan, renamed the “Inflation Reduction Act of 2022,” which includes sweeping drug price controls along with tax increases and billions for climate and energy spending. The bill’s drug pricing provisions would allow Medicare to negotiate drug prices […]

July 28, 2022
BioUtah News
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022

UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections.

July 28, 2022
BioUtah News
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-0390, an Investigational Emopamil-binding Protein (EBP) Inhibitor for the Treatment of Brain Cancer

Sumitomo Pharma Oncology recently announced the U.S. FDA granted Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of brain cancer. 

July 28, 2022
BioUtah News
Forbes Magazine Recognizes ARUP Among Nation’s Best Employers for Women

ARUP Laboratories’ ongoing commitment to provide an environment of diversity, inclusion, and belonging for all employees has earned the company recognition as one of Forbes magazine’s Best Employers for Women 2022. The Forbes ranking, first published online on Tuesday, July 26, places ARUP 236th on a list of 300 companies nationwide. Winners were chosen based […]

July 28, 2022
BioUtah News
Published UCLA and Spectrum Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers

Spectrum Solutions announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry.

July 28, 2022
BioUtah News
Clene’s ALS Drug Increases Survival by 70% in Mid-stage Study

Shares of Clene, Inc. surged Thursday after the company released “golden” data from an interim analysis of a Phase II study.

July 28, 2022
BioUtah News
Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need

Only balloon configuration specifically designed to dilate small airways, providing minimally invasive treatment to patients with lung obstructions

July 27, 2022
BioUtah News
Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACC

Co-Diagnostics announced that it will be disclosing the global expansion of its OEM agreement with Bio Molecular Systems (BMS) at the Company’s customer and distributor update today at AACC.

July 25, 2022
BioUtah News
ARUP’s New Monkeypox Test Can Be Performed on More Specimen Types on High-Throughput Instruments

SALT LAKE CITY, July 25, 2022 — ARUP Laboratories today announced that it has begun in-house testing for monkeypox. The Orthopoxvirus (includes monkeypox virus) by PCR test (test code 3005716) is a real-time polymerase chain reaction (RT-PCR) test to detect the DNA of orthopoxviruses, including monkeypox. ARUP’s test is similar to the CDC assay that […]

July 21, 2022
Industry News
BD Completes Acquisition of Parata Systems

BD (Becton, Dickinson and Company) (NYSE: BDX) today announced it has completed the acquisition of Parata Systems. Parata advances BD’s transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce costs, enhance patient safety and improve the patient experience for retail, hospital and long-term care […]